Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T08:48:54.073Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug treatment of personality disorders

Published online by Cambridge University Press:  03 January 2018

Paul J. Markovitz  and
S. Charles Schulz
Paul J. Markovitz
Affiliation:
11400 Euclid Avenue, Suite 200, Cleveland, Ohio 44106, USA
S. Charles Schulz
Affiliation:
11400 Euclid Avenue, Suite 200, Cleveland, Ohio 44106, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 162 , Issue 1 , January 1993 , pp. 122
Copyright
Copyright © The Royal College of Psychiatrists 

References

Coccaro, E. F., Siever, L. J., Klar, H. M., et al (1989) Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry, 46, 587–599.Google Scholar
Cornelius, J. R., Soloff, P. H., Perel, J. M., et al (1991) A preliminary trial of fluoxetine in refractory borderline patients. Journal of Clinical Psychopharmacology, 11, 116–120.Google Scholar
Markovitz, P. J., Calabrese, J. R., Schulz, S. C., et al (1991a) Fluoxetine in borderline and schizotypal personality disorder. American Journal of Psychiatry. 148, 1064–1067.Google Scholar
Norden, M. J. (1989) Fluoxetine in borderline personality disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 13, 885–893.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.